NUK - logo
E-viri
Celotno besedilo
Recenzirano Odprti dostop
  • RIP(K)ing away immunotherap...
    Patel, Mira A; Tavazoie, Sohail F

    Immunity, 04/2022, Letnik: 55, Številka: 4
    Journal Article

    Interferon signaling mediates resistance to immune checkpoint blockade therapy, but the underlying mechanisms are poorly understood. In this issue of Immunity, Cucolo et al. identify RIPK1 as an interferon-stimulated gene with potent effects on cell extrinsic and intrinsic immunotherapy resistance.